US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

79.14

+0.46500.59%

Volume:110.60K

Turnover:8.83M

Market Cap:3.04B

PE:-12.06

High:80.30

Open:79.44

Low:77.68

Close:78.67

52wk High:99.50

52wk Low:40.00

Shares:38.39M

Float Shares:32.95M

Volume Ratio:0.59

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.5619

EPS(LYR):-6.0116

ROE:-39.08%

ROA:-23.96%

PB:4.72

PE(LYR):-13.16

Loading ...

Overview Company News Filings

Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss

MT Newswires Live

Disc Medicine Q1 Net Income USD -63.504 Million VS. Ibes Estimate USD -67.1 Million

THOMSON REUTERS

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation

Simply Wall St.

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026

Press Release: CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER PRODUCTION AND SALES

Disc Medicine announces annual shareholder meeting via webcast

Mabwell Q1 net loss narrows to RMB 241.94 million; revenue triples to RMB 127.6 million

Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?

Simply Wall St.

Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch

Disc Medicine to present Phase 2 RALLY-MF data for DISC-0974 at ASCO 2026

Disc Medicine Announces Oral Presentation of Data From Rally-Mf Phase 2 Trial of Disc-0974 in Patients With Myelofibrosis and Anemia at the American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS

Disc Medicine CMO William Jacob Savage disposes of $379,087 common shares

Disc Medicine CFO Jean M. Franchi disposes of USD 460,996 common shares

Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns

Simply Wall St.

Assessing Disc Medicine (IRON) Valuation After FDA Complete Response Letter And Shareholder Investigation

Simply Wall St.

Wedbush Keeps Their Buy Rating on Disc Medicine (IRON)

BRIEF-Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic Protoporphyria

Disc Medicine completes Phase 3 APOLLO enrollment for bitopertin in EPP; trial size grows to 183 participants

Disc Medicine completes enrollment in APOLLO trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IRON/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRON\",,,,,undefined,":{"symbol":"IRON","market":"US","secType":"STK","nameCN":"Disc Medicine","latestPrice":79.135,"timestamp":1788363037104,"preClose":78.67,"halted":0,"volume":110598,"delay":0,"changeRate":0.005910766492945257,"floatShares":32946500,"shares":38392844,"eps":-6.561909,"marketStatus":"Trading","change":0.465,"latestTime":"09-02 11:31:01 EDT","open":79.44,"high":80.3,"low":77.6804,"amount":8828944.88469,"amplitude":0.033299,"askPrice":79.21,"askSize":60,"bidPrice":79.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.561909,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1597204800000,"exchange":"NASDAQ","adjPreClose":78.67,"preHourTrading":{"tag":"盘前","latestPrice":79.31,"preClose":78.67,"latestTime":"09:29 EDT","volume":654,"amount":51682.12764,"timestamp":1788355799981,"change":0.64,"changeRate":0.008135,"amplitude":0.016525},"postHourTrading":{"tag":"盘后","latestPrice":78.67,"preClose":78.67,"latestTime":"19:30 EDT","volume":19731,"amount":1552237.77,"timestamp":1788305406311,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.58767,"impliedVol":0.5266,"impliedVolPercentile":0.504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRON\",,,,,undefined,":{"symbol":"IRON","floatShares":32946500,"roa":"-23.96%","roe":"-39.08%","lyrEps":-6.011616,"volumeRatio":0.58767,"shares":38392844,"dividePrice":0,"high":80.3,"amplitude":0.033299,"preClose":78.67,"low":77.6804,"week52Low":40.0001,"pbRate":"4.72","week52High":99.5,"institutionHeld":0,"latestPrice":79.135,"committee":0.25,"eps":-6.561909,"divideRate":0,"volume":110598,"delay":0,"ttmEps":-6.561909,"open":79.44,"prevYearClose":79.41,"prevWeekClose":80.03,"prevMonthClose":78.65,"prevQuarterClose":73.14,"fiveDayClose":82.67,"twentyDayClose":78.91,"sixtyDayClose":65.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"IRON","fiscalQuarterEnding":"2026/06","expectedEps":-1.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"pre","actualEps":-1.54},{"market":"US","date":"2026-05-05","symbol":"IRON","fiscalQuarterEnding":"2026/03","expectedEps":-1.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-1.65},{"market":"US","date":"2026-02-26","symbol":"IRON","fiscalQuarterEnding":"2025/12","expectedEps":-1.69,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-1.62},{"market":"US","date":"2025-11-06","symbol":"IRON","fiscalQuarterEnding":"2025/09","expectedEps":-1.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2025-08-07","symbol":"IRON","fiscalQuarterEnding":"2025/06","expectedEps":-1.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-1.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1762228800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRON","date":"2026-08-31","current":-11.988889,"percent":0.716795,"low":-28.3686,"twenty":-18.352313,"median":-15.797839,"eighty":-11.222342,"high":-6.836498,"avg":-15.439699,"sd":4.097148,"marketCap":3072579305},"quantilePoints":[{"date":"2022-12-30","current":-7.575373,"twenty":-7.575373,"median":-7.575373,"eighty":-7.575373,"marketCap":336604138},{"date":"2023-01-06","current":-7.228788,"twenty":-7.298105,"median":-6.931714,"eighty":-6.836498,"marketCap":321203949},{"date":"2023-01-13","current":-7.331621,"twenty":-7.316387,"median":-7.198319,"eighty":-6.912671,"marketCap":325773236},{"date":"2023-01-20","current":-8.081922,"twenty":-7.429122,"median":-7.276395,"eighty":-7.068825,"marketCap":359112107},{"date":"2023-01-27","current":-8.413273,"twenty":-8.215986,"median":-7.312578,"eighty":-7.164802,"marketCap":373835365},{"date":"2023-02-03","current":-8.847457,"twenty":-8.312725,"median":-7.670589,"eighty":-7.204412,"marketCap":393127910},{"date":"2023-02-10","current":-9.237842,"twenty":-8.701206,"median":-7.899107,"eighty":-7.237928,"marketCap":410474277},{"date":"2023-02-17","current":-10.169388,"twenty":-9.220703,"median":-8.211415,"eighty":-7.28287,"marketCap":451866600},{"date":"2023-02-24","current":-10.398869,"twenty":-9.839034,"median":-8.32377,"eighty":-7.310293,"marketCap":462063339},{"date":"2023-03-03","current":-10.354248,"twenty":-10.3262,"median":-8.573235,"eighty":-7.312578,"marketCap":460080640},{"date":"2023-03-10","current":-8.958241,"twenty":-10.355522,"median":-8.902849,"eighty":-7.320195,"marketCap":398050478},{"date":"2023-03-17","current":-9.247216,"twenty":-10.3262,"median":-9.178808,"eighty":-7.429122,"marketCap":410890816},{"date":"2023-03-24","current":-9.68068,"twenty":-10.238233,"median":-9.200624,"eighty":-7.651546,"marketCap":430151323},{"date":"2023-03-31","current":-8.544805,"twenty":-10.157489,"median":-9.234468,"eighty":-7.809985,"marketCap":400127591},{"date":"2023-04-06","current":-8.96015,"twenty":-10.134541,"median":-9.191971,"eighty":-7.880825,"marketCap":419576927},{"date":"2023-04-14","current":-8.956117,"twenty":-10.105644,"median":-9.138818,"eighty":-7.93567,"marketCap":419388098},{"date":"2023-04-21","current":-11.877928,"twenty":-10.163439,"median":-9.183472,"eighty":-8.101727,"marketCap":556207747},{"date":"2023-04-28","current":-13.627915,"twenty":-10.355947,"median":-9.221872,"eighty":-8.193134,"marketCap":638154368},{"date":"2023-05-05","current":-13.25171,"twenty":-10.489811,"median":-9.247216,"eighty":-8.247216,"marketCap":620537824},{"date":"2023-05-12","current":-13.708228,"twenty":-10.676796,"median":-9.368332,"eighty":-8.290635,"marketCap":641915204},{"date":"2023-05-19","current":-11.12339,"twenty":-11.026123,"median":-9.42637,"eighty":-8.385851,"marketCap":664678154},{"date":"2023-05-26","current":-10.61952,"twenty":-11.097552,"median":-9.559565,"eighty":-8.439579,"marketCap":634569391},{"date":"2023-06-02","current":-13.170855,"twenty":-11.12339,"median":-9.62331,"eighty":-8.544805,"marketCap":787024440},{"date":"2023-06-09","current":-13.078079,"twenty":-12.302738,"median":-9.706178,"eighty":-8.544805,"marketCap":781480620},{"date":"2023-06-16","current":-18.240785,"twenty":-12.947365,"median":-9.922909,"eighty":-8.544805,"marketCap":1089978082},{"date":"2023-06-23","current":-20.124906,"twenty":-13.13409,"median":-10.126892,"eighty":-8.567549,"marketCap":1202563772},{"date":"2023-06-30","current":-17.44624,"twenty":-13.285526,"median":-10.226758,"eighty":-8.577952,"marketCap":1042500097},{"date":"2023-07-07","current":-16.501782,"twenty":-13.518837,"median":-10.329598,"eighty":-8.59014,"marketCap":986064002},{"date":"2023-07-14","current":-17.832269,"twenty":-13.77231,"median":-10.364872,"eighty":-8.630148,"marketCap":1065567232},{"date":"2023-07-21","current":-17.285083,"twenty":-14.480928,"median":-10.460489,"eighty":-8.71175,"marketCap":1032870129},{"date":"2023-07-28","current":-17.382527,"twenty":-16.378853,"median":-10.600014,"eighty":-8.800464,"marketCap":1038692900},{"date":"2023-08-04","current":-18.757988,"twenty":-16.856045,"median":-10.636849,"eighty":-8.842488,"marketCap":1120883563},{"date":"2023-08-11","current":-19.496314,"twenty":-17.209377,"median":-10.735489,"eighty":-8.870579,"marketCap":1165002257},{"date":"2023-08-18","current":-17.68009,"twenty":-17.296326,"median":-10.83932,"eighty":-8.925603,"marketCap":1169042907},{"date":"2023-08-25","current":-19.347762,"twenty":-17.475473,"median":-11.000563,"eighty":-8.956967,"marketCap":1279312707},{"date":"2023-09-01","current":-18.320171,"twenty":-17.881741,"median":-11.115108,"eighty":-8.959005,"marketCap":1211366378},{"date":"2023-09-08","current":-18.565824,"twenty":-17.967897,"median":-11.237671,"eighty":-8.983538,"marketCap":1227609440},{"date":"2023-09-15","current":-18.278653,"twenty":-18.162498,"median":-12.302738,"eighty":-9.081438,"marketCap":1208621072},{"date":"2023-09-22","current":-16.953511,"twenty":-18.162498,"median":-12.802333,"eighty":-9.114823,"marketCap":1121000048},{"date":"2023-09-29","current":-16.251151,"twenty":-18.152411,"median":-12.978676,"eighty":-9.179741,"marketCap":1074558617},{"date":"2023-10-06","current":-15.635289,"twenty":-18.125725,"median":-13.147877,"eighty":-9.185172,"marketCap":1033836574},{"date":"2023-10-13","current":-15.880942,"twenty":-18.038694,"median":-13.25171,"eighty":-9.195432,"marketCap":1050079636},{"date":"2023-10-20","current":-15.195882,"twenty":-17.967897,"median":-13.43556,"eighty":-9.214315,"marketCap":1004782083},{"date":"2023-10-27","current":-15.576471,"twenty":-17.94682,"median":-13.511646,"eighty":-9.224392,"marketCap":1029947391},{"date":"2023-11-03","current":-15.880942,"twenty":-17.923627,"median":-13.708228,"eighty":-9.236492,"marketCap":1050079636},{"date":"2023-11-10","current":-18.233191,"twenty":-17.923627,"median":-13.807564,"eighty":-9.243466,"marketCap":1168638119},{"date":"2023-11-17","current":-18.214359,"twenty":-18.148064,"median":-14.257741,"eighty":-9.274727,"marketCap":1167431098},{"date":"2023-11-24","current":-20.255753,"twenty":-18.215568,"median":-14.89833,"eighty":-9.320623,"marketCap":1298272217},{"date":"2023-12-01","current":-20.78305,"twenty":-18.287533,"median":-15.167455,"eighty":-9.367057,"marketCap":1332068817},{"date":"2023-12-08","current":-21.683222,"twenty":-18.336087,"median":-15.458834,"eighty":-9.388158,"marketCap":1389764439},{"date":"2023-12-15","current":-21.939338,"twenty":-18.428812,"median":-15.638749,"eighty":-9.41555,"marketCap":1406179931},{"date":"2023-12-22","current":-21.950637,"twenty":-18.579931,"median":-15.794444,"eighty":-9.436302,"marketCap":1406904143},{"date":"2023-12-29","current":-21.461004,"twenty":-18.70177,"median":-15.865372,"eighty":-9.451199,"marketCap":1375521587},{"date":"2024-01-05","current":-22.971334,"twenty":-18.744411,"median":-15.880942,"eighty":-9.514944,"marketCap":1472324703},{"date":"2024-01-12","current":-23.351742,"twenty":-18.89338,"median":-16.190264,"eighty":-9.55999,"marketCap":1496706536},{"date":"2024-01-19","current":-23.378107,"twenty":-19.028759,"median":-16.230391,"eighty":-9.576989,"marketCap":1498396365},{"date":"2024-01-26","current":-23.841375,"twenty":-19.308706,"median":-16.251151,"eighty":-9.618635,"marketCap":1528089092},{"date":"2024-02-02","current":-25.491063,"twenty":-19.47008,"median":-16.452691,"eighty":-9.660282,"marketCap":1633824167},{"date":"2024-02-09","current":-25.133254,"twenty":-19.661941,"median":-16.501782,"eighty":-9.690879,"marketCap":1610890760},{"date":"2024-02-16","current":-24.83759,"twenty":-20.115476,"median":-16.551189,"eighty":-9.724876,"marketCap":1591940524},{"date":"2024-02-23","current":-24.474132,"twenty":-20.382304,"median":-16.697479,"eighty":-9.757174,"marketCap":1568645011},{"date":"2024-03-01","current":-25.863937,"twenty":-20.921654,"median":-16.835874,"eighty":-9.833667,"marketCap":1657723190},{"date":"2024-03-08","current":-23.600325,"twenty":-21.46703,"median":-16.854059,"eighty":-10.080146,"marketCap":1512639218},{"date":"2024-03-15","current":-23.739682,"twenty":-21.928039,"median":-16.946591,"eighty":-10.119243,"marketCap":1521571176},{"date":"2024-03-22","current":-19.830979,"twenty":-22.025965,"median":-17.017819,"eighty":-10.14559,"marketCap":1515661929},{"date":"2024-03-28","current":-19.540345,"twenty":-21.950637,"median":-17.068855,"eighty":-10.169388,"marketCap":1493449004},{"date":"2024-04-05","current":-9.526362,"twenty":-21.939338,"median":-17.030229,"eighty":-10.139641,"marketCap":728090326},{"date":"2024-04-12","current":-10.346598,"twenty":-21.882842,"median":-16.950051,"eighty":-10.139641,"marketCap":790780137},{"date":"2024-04-19","current":-9.694284,"twenty":-21.815046,"median":-16.865324,"eighty":-9.855748,"marketCap":740924460},{"date":"2024-04-26","current":-8.564038,"twenty":-21.683222,"median":-16.839001,"eighty":-9.752924,"marketCap":654540862},{"date":"2024-05-03","current":-9.380242,"twenty":-21.468537,"median":-16.756297,"eighty":-9.68068,"marketCap":716922485},{"date":"2024-05-10","current":-9.438139,"twenty":-21.461004,"median":-16.551189,"eighty":-9.646683,"marketCap":760685662},{"date":"2024-05-17","current":-9.79088,"twenty":-21.332946,"median":-16.501782,"eighty":-9.635772,"marketCap":789115578},{"date":"2024-05-24","current":-10.229507,"twenty":-21.005268,"median":-16.452691,"eighty":-9.635772,"marketCap":824467561},{"date":"2024-05-31","current":-10.413546,"twenty":-20.979234,"median":-16.252881,"eighty":-9.644501,"marketCap":839300560},{"date":"2024-06-07","current":-11.99935,"twenty":-20.947536,"median":-16.240771,"eighty":-9.661513,"marketCap":967111573},{"date":"2024-06-14","current":-17.030787,"twenty":-20.862898,"median":-16.207235,"eighty":-9.677588,"marketCap":1372630365},{"date":"2024-06-21","current":-16.261513,"twenty":-20.807155,"median":-16.207235,"eighty":-9.688842,"marketCap":1310629123},{"date":"2024-06-28","current":-16.589098,"twenty":-20.564975,"median":-16.240771,"eighty":-9.70142,"marketCap":1337031566},{"date":"2024-07-05","current":-17.159613,"twenty":-20.417332,"median":-16.247691,"eighty":-9.710361,"marketCap":1383013348},{"date":"2024-07-12","current":-17.362054,"twenty":-20.350666,"median":-16.258062,"eighty":-9.718029,"marketCap":1399329465},{"date":"2024-07-19","current":-16.710563,"twenty":-20.255753,"median":-16.353531,"eighty":-9.733241,"marketCap":1346821236},{"date":"2024-07-26","current":-16.809943,"twenty":-20.203414,"median":-16.392179,"eighty":-9.755229,"marketCap":1354830966},{"date":"2024-08-02","current":-15.768293,"twenty":-20.117131,"median":-16.324085,"eighty":-9.761748,"marketCap":1270877131},{"date":"2024-08-09","current":-14.075329,"twenty":-20.103813,"median":-16.252881,"eighty":-9.768796,"marketCap":1280883127},{"date":"2024-08-16","current":-15.65958,"twenty":-19.99319,"median":-16.240771,"eighty":-9.773154,"marketCap":1425053078},{"date":"2024-08-23","current":-16.139755,"twenty":-19.814977,"median":-16.207235,"eighty":-9.775802,"marketCap":1468749949},{"date":"2024-08-30","current":-16.60033,"twenty":-19.770487,"median":-16.194459,"eighty":-9.7833,"marketCap":1510663275},{"date":"2024-09-06","current":-16.446805,"twenty":-19.724797,"median":-16.205085,"eighty":-9.802562,"marketCap":1496692167},{"date":"2024-09-13","current":-15.610582,"twenty":-19.663454,"median":-16.190264,"eighty":-9.850582,"marketCap":1420594213},{"date":"2024-09-20","current":-15.71511,"twenty":-19.64045,"median":-16.165813,"eighty":-9.858725,"marketCap":1430106457},{"date":"2024-09-27","current":-16.355343,"twenty":-19.570656,"median":-16.15772,"eighty":-9.882287,"marketCap":1488368953},{"date":"2024-10-04","current":-16.309612,"twenty":-19.558255,"median":-16.165813,"eighty":-9.957457,"marketCap":1484207346},{"date":"2024-10-11","current":-15.597516,"twenty":-19.531539,"median":-16.146288,"eighty":-10.080146,"marketCap":1419405183},{"date":"2024-10-18","current":-16.515402,"twenty":-19.495286,"median":-16.139755,"eighty":-10.119243,"marketCap":1502934577},{"date":"2024-10-25","current":-15.029146,"twenty":-19.487444,"median":-16.13438,"eighty":-10.14559,"marketCap":1367682355},{"date":"2024-11-01","current":-15.394994,"twenty":-19.465712,"median":-16.090757,"eighty":-10.170369,"marketCap":1400975210},{"date":"2024-11-08","current":-21.232221,"twenty":-19.531539,"median":-16.13438,"eighty":-10.175171,"marketCap":1932174595},{"date":"2024-11-15","current":-17.099071,"twenty":-19.531539,"median":-16.16262,"eighty":-10.188842,"marketCap":1769394744},{"date":"2024-11-22","current":-18.68072,"twenty":-19.495286,"median":-16.184145,"eighty":-10.236133,"marketCap":1933062270},{"date":"2024-11-29","current":-18.246486,"twenty":-19.491172,"median":-16.199772,"eighty":-10.262637,"marketCap":1888128095},{"date":"2024-12-06","current":-18.64046,"twenty":-19.47253,"median":-16.240771,"eighty":-10.278783,"marketCap":1928896188},{"date":"2024-12-13","current":-18.66059,"twenty":-19.438442,"median":-16.249421,"eighty":-10.284129,"marketCap":1930979229},{"date":"2024-12-20","current":-18.548437,"twenty":-19.402528,"median":-16.261513,"eighty":-10.304949,"marketCap":1919373714},{"date":"2024-12-27","current":-18.439159,"twenty":-19.37809,"median":-16.316145,"eighty":-10.336976,"marketCap":1908065775},{"date":"2025-01-03","current":-18.352888,"twenty":-19.359526,"median":-16.353531,"eighty":-10.345952,"marketCap":1899138456},{"date":"2025-01-10","current":-17.037243,"twenty":-19.349838,"median":-16.381475,"eighty":-10.349658,"marketCap":1762996832},{"date":"2025-01-17","current":-16.74967,"twenty":-19.308706,"median":-16.399594,"eighty":-10.355098,"marketCap":1733239100},{"date":"2025-01-24","current":-18.696366,"twenty":-19.242934,"median":-16.438935,"eighty":-10.357001,"marketCap":1934681259},{"date":"2025-01-31","current":-18.159395,"twenty":-19.209149,"median":-16.482964,"eighty":-10.360586,"marketCap":1879116001},{"date":"2025-02-07","current":-17.840466,"twenty":-19.179918,"median":-16.497159,"eighty":-10.371671,"marketCap":1846113605},{"date":"2025-02-14","current":-17.606151,"twenty":-19.122869,"median":-16.515402,"eighty":-10.401419,"marketCap":1821866947},{"date":"2025-02-21","current":-17.746089,"twenty":-19.039831,"median":-16.546757,"eighty":-10.411618,"marketCap":1836347590},{"date":"2025-02-28","current":-17.759163,"twenty":-19.031559,"median":-16.569985,"eighty":-10.413546,"marketCap":1942088779},{"date":"2025-03-07","current":-17.597946,"twenty":-19.027337,"median":-16.60033,"eighty":-10.471825,"marketCap":1924458568},{"date":"2025-03-14","current":-16.128026,"twenty":-19.012152,"median":-16.615329,"eighty":-10.509359,"marketCap":1763712522},{"date":"2025-03-21","current":-16.513682,"twenty":-18.959666,"median":-16.630327,"eighty":-10.517859,"marketCap":1805886754},{"date":"2025-03-28","current":-16.551616,"twenty":-18.953333,"median":-16.615329,"eighty":-10.600014,"marketCap":1810035039},{"date":"2025-04-04","current":-13.03013,"twenty":-18.922194,"median":-16.589098,"eighty":-10.61952,"marketCap":1424935911},{"date":"2025-04-11","current":-12.243011,"twenty":-18.874171,"median":-16.57571,"eighty":-10.622124,"marketCap":1338858996},{"date":"2025-04-17","current":-13.328856,"twenty":-18.852845,"median":-16.555797,"eighty":-10.623705,"marketCap":1457603655},{"date":"2025-04-25","current":-14.384337,"twenty":-18.840827,"median":-16.546757,"eighty":-10.629881,"marketCap":1573027953},{"date":"2025-05-02","current":-15.679624,"twenty":-18.813199,"median":-16.514542,"eighty":-10.645944,"marketCap":1714676661},{"date":"2025-05-09","current":-13.152904,"twenty":-18.767732,"median":-16.501782,"eighty":-10.676796,"marketCap":1532221210},{"date":"2025-05-16","current":-14.297539,"twenty":-18.739885,"median":-16.487628,"eighty":-10.72511,"marketCap":1665563246},{"date":"2025-05-23","current":-14.282674,"twenty":-18.717483,"median":-16.446805,"eighty":-10.769949,"marketCap":1663831531},{"date":"2025-05-30","current":-13.934824,"twenty":-18.706268,"median":-16.401381,"eighty":-10.785327,"marketCap":1623309406},{"date":"2025-06-06","current":-14.273755,"twenty":-18.698528,"median":-16.382226,"eighty":-10.817723,"marketCap":1662792502},{"date":"2025-06-13","current":-15.671102,"twenty":-18.695606,"median":-16.353531,"eighty":-10.867809,"marketCap":1825573689},{"date":"2025-06-20","current":-14.892155,"twenty":-18.693949,"median":-16.316145,"eighty":-10.926881,"marketCap":1734831836},{"date":"2025-06-27","current":-16.093279,"twenty":-18.687622,"median":-16.285563,"eighty":-10.990623,"marketCap":1874754388},{"date":"2025-07-03","current":-16.27761,"twenty":-18.680101,"median":-16.258062,"eighty":-11.009921,"marketCap":1896227651},{"date":"2025-07-11","current":-17.243861,"twenty":-18.67422,"median":-16.261513,"eighty":-11.049971,"marketCap":2008789110},{"date":"2025-07-18","current":-17.181426,"twenty":-18.656564,"median":-16.293611,"eighty":-11.069727,"marketCap":2001515908},{"date":"2025-07-25","current":-18.010916,"twenty":-18.633558,"median":-16.324085,"eighty":-11.109881,"marketCap":2098145591},{"date":"2025-08-01","current":-17.767123,"twenty":-18.603651,"median":-16.354437,"eighty":-11.122355,"marketCap":2069745469},{"date":"2025-08-08","current":-13.595202,"twenty":-18.593426,"median":-16.381475,"eighty":-11.126036,"marketCap":1976579215},{"date":"2025-08-15","current":-14.519534,"twenty":-18.584633,"median":-16.352734,"eighty":-11.145985,"marketCap":2110966078},{"date":"2025-08-22","current":-14.287585,"twenty":-18.565222,"median":-16.316145,"eighty":-11.186007,"marketCap":2077243464},{"date":"2025-08-29","current":-14.266064,"twenty":-18.55994,"median":-16.27761,"eighty":-11.200449,"marketCap":2074114562},{"date":"2025-09-05","current":-14.392799,"twenty":-18.548437,"median":-16.258062,"eighty":-11.217183,"marketCap":2092540320},{"date":"2025-09-12","current":-14.416712,"twenty":-18.548437,"median":-16.247691,"eighty":-11.279077,"marketCap":2096016878},{"date":"2025-09-19","current":-14.976259,"twenty":-18.546665,"median":-16.230391,"eighty":-11.640473,"marketCap":2177368338},{"date":"2025-09-26","current":-14.945173,"twenty":-18.536934,"median":-16.205085,"eighty":-11.877928,"marketCap":2172848812},{"date":"2025-10-03","current":-15.748625,"twenty":-18.521873,"median":-16.190264,"eighty":-11.916532,"marketCap":2289661164},{"date":"2025-10-10","current":-16.917936,"twenty":-18.482787,"median":-16.205085,"eighty":-11.99935,"marketCap":2459664855},{"date":"2025-10-17","current":-17.781169,"twenty":-18.482295,"median":-16.213876,"eighty":-12.002417,"marketCap":2585168603},{"date":"2025-10-24","current":-20.012184,"twenty":-18.546665,"median":-16.240771,"eighty":-12.011619,"marketCap":2909531473},{"date":"2025-10-31","current":-20.504777,"twenty":-18.565824,"median":-16.249421,"eighty":-12.183389,"marketCap":2981148570},{"date":"2025-11-07","current":-16.700378,"twenty":-18.594449,"median":-16.261513,"eighty":-12.233528,"marketCap":3024605547},{"date":"2025-11-14","current":-18.142422,"twenty":-18.589335,"median":-16.293611,"eighty":-12.243011,"marketCap":3285774100},{"date":"2025-11-21","current":-18.832351,"twenty":-18.66059,"median":-16.324085,"eighty":-12.302738,"marketCap":3410727136},{"date":"2025-11-28","current":-19.459749,"twenty":-18.687601,"median":-16.353531,"eighty":-12.373815,"marketCap":3524355124},{"date":"2025-12-05","current":-19.549377,"twenty":-18.701182,"median":-16.382226,"eighty":-12.572442,"marketCap":3540587693},{"date":"2025-12-12","current":-19.509774,"twenty":-18.738082,"median":-16.401381,"eighty":-12.685289,"marketCap":3533415163},{"date":"2025-12-19","current":-18.851111,"twenty":-18.811838,"median":-16.46056,"eighty":-12.724299,"marketCap":3414124651},{"date":"2025-12-26","current":-16.764649,"twenty":-18.777477,"median":-16.487628,"eighty":-12.83341,"marketCap":3036245529},{"date":"2026-01-02","current":-16.552042,"twenty":-18.754383,"median":-16.487628,"eighty":-12.920427,"marketCap":2997740364},{"date":"2026-01-09","current":-16.52703,"twenty":-18.743529,"median":-16.485342,"eighty":-12.947523,"marketCap":2993210344},{"date":"2026-01-16","current":-14.807418,"twenty":-18.726421,"median":-16.472533,"eighty":-12.952891,"marketCap":2681771508},{"date":"2026-01-23","current":-16.299833,"twenty":-18.711452,"median":-16.438935,"eighty":-12.964203,"marketCap":2952062668},{"date":"2026-01-30","current":-16.372786,"twenty":-18.704517,"median":-16.431066,"eighty":-12.988967,"marketCap":2965275225},{"date":"2026-02-06","current":-16.326929,"twenty":-18.701623,"median":-16.438935,"eighty":-13.03582,"marketCap":2956970189},{"date":"2026-02-13","current":-14.934565,"twenty":-18.700101,"median":-16.401381,"eighty":-13.06248,"marketCap":2704799107},{"date":"2026-02-20","current":-13.204532,"twenty":-18.696366,"median":-16.389461,"eighty":-13.05858,"marketCap":2391472762},{"date":"2026-02-27","current":-12.08203,"twenty":-18.695099,"median":-16.37713,"eighty":-12.978676,"marketCap":2563613501},{"date":"2026-03-06","current":-10.8518,"twenty":-18.692223,"median":-16.353531,"eighty":-12.902468,"marketCap":2302578322},{"date":"2026-03-13","current":-10.74749,"twenty":-18.686445,"median":-16.325507,"eighty":-12.617657,"marketCap":2280445484},{"date":"2026-03-20","current":-10.641382,"twenty":-18.68072,"median":-16.316145,"eighty":-12.233528,"marketCap":2257931046},{"date":"2026-03-27","current":-11.15214,"twenty":-18.677627,"median":-16.293579,"eighty":-12.002417,"marketCap":2366305630},{"date":"2026-04-02","current":-11.650308,"twenty":-18.663997,"median":-16.27761,"eighty":-11.956774,"marketCap":2472009010},{"date":"2026-04-10","current":-12.103516,"twenty":-18.644486,"median":-16.254611,"eighty":-11.913644,"marketCap":2568172374},{"date":"2026-04-17","current":-12.490181,"twenty":-18.612854,"median":-16.245987,"eighty":-11.917927,"marketCap":2650216514},{"date":"2026-04-24","current":-12.286957,"twenty":-18.59675,"median":-16.234045,"eighty":-11.92547,"marketCap":2607095640},{"date":"2026-05-01","current":-11.860726,"twenty":-18.590358,"median":-16.207397,"eighty":-11.917927,"marketCap":2516656286},{"date":"2026-05-08","current":-10.676956,"twenty":-18.570526,"median":-16.203283,"eighty":-11.901784,"marketCap":2579584480},{"date":"2026-05-15","current":-11.020047,"twenty":-18.563418,"median":-16.184145,"eighty":-11.85605,"marketCap":2662476503},{"date":"2026-05-22","current":-10.613713,"twenty":-18.551313,"median":-16.16262,"eighty":-11.648341,"marketCap":2564304844},{"date":"2026-05-29","current":-11.193965,"twenty":-18.548437,"median":-16.152821,"eighty":-11.530532,"marketCap":2704495501},{"date":"2026-06-05","current":-11.242978,"twenty":-18.547374,"median":-16.128516,"eighty":-11.267149,"marketCap":2716337218},{"date":"2026-06-12","current":-10.763914,"twenty":-18.540826,"median":-16.116407,"eighty":-11.195345,"marketCap":2600593979},{"date":"2026-06-18","current":-11.100682,"twenty":-18.53091,"median":-16.093279,"eighty":-11.142828,"marketCap":2681958038},{"date":"2026-06-26","current":-11.092777,"twenty":-18.506239,"median":-16.076937,"eighty":-11.130235,"marketCap":2680048084},{"date":"2026-07-02","current":-11.850108,"twenty":-18.482689,"median":-16.041175,"eighty":-11.137022,"marketCap":2863021720},{"date":"2026-07-10","current":-12.480955,"twenty":-18.479419,"median":-16.026779,"eighty":-11.14133,"marketCap":3015436085},{"date":"2026-07-17","current":-11.61611,"twenty":-18.466739,"median":-15.973253,"eighty":-11.158401,"marketCap":2806487068},{"date":"2026-07-24","current":-11.993986,"twenty":-18.457453,"median":-15.926565,"eighty":-11.185231,"marketCap":2897782891},{"date":"2026-07-31","current":-12.305399,"twenty":-18.439159,"median":-15.912081,"eighty":-11.192384,"marketCap":3025749839},{"date":"2026-08-07","current":-12.091447,"twenty":-18.407671,"median":-15.883509,"eighty":-11.193965,"marketCap":2973141839},{"date":"2026-08-14","current":-12.492726,"twenty":-18.37899,"median":-15.870298,"eighty":-11.193965,"marketCap":3071811448},{"date":"2026-08-21","current":-12.310043,"twenty":-18.364464,"median":-15.846153,"eighty":-11.196265,"marketCap":3026891820},{"date":"2026-08-28","current":-12.889321,"twenty":-18.352888,"median":-15.801233,"eighty":-11.217183,"marketCap":3169329272},{"date":"2026-08-31","current":-12.495849,"twenty":-18.352313,"median":-15.797839,"eighty":-11.222342,"marketCap":3072579305}],"updateTime":1788327421567},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRON\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633480949","title":"Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633480949","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633480949?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:37","pubTimestamp":1777984625,"startTime":"0","endTime":"0","summary":"Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633950948","title":"Disc Medicine Q1 Net Income USD -63.504 Million VS. Ibes Estimate USD -67.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633950948","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633950948?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXD2711E:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948138","title":"Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948138?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984200,"startTime":"0","endTime":"0","summary":"-- Completed enrollment of the Phase 3 APOLLO study of bitopertin in. erythropoietic protoporphyria ; topline data expected in Q4 2026. -- Updated data from Phase 2 study of DISC-0974 in patients with anemia of. myelofibrosis  to be shared at the American Society of Clinical. -- Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera . and Phase 1b study of DISC-3405 in sickle cell disease , with data. cash, cash equivalents, and marketable securities, providing runway into. adults and adolescents with EPP, with topline data expected Q4 2026;anemia of myelofibrosis  to be shared in an oral presentation at ASCO. -- Progressing Phase 2 study in patients with inflammatory bowel disease","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","IBD","LU0053671581.USD","SCD","BK4139","BK4582","EPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925449","title":"How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925449","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925449?lang=en_us&edition=fundamental","pubTime":"2026-05-05 14:23","pubTimestamp":1777962235,"startTime":"0","endTime":"0","summary":"Rosen Law Firm recently launched a shareholder investigation into Disc Medicine, Inc. after investors alleged the company issued materially misleading business information, following an FDA Complete Response Letter on its bitopertin program.\nThis combination of regulatory setback and legal scrutiny raises questions about Disc Medicine’s prior disclosures and how it communicates key clinical and regulatory developments to investors.\nWe will now examine how the shareholder investigation linked...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/how-investors-are-reacting-to-disc-medicine-iron-after-fda-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/how-investors-are-reacting-to-disc-medicine-iron-after-fda-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LABU","BK4585","BK4588","IRON","ISBC","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633962733","title":"Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633962733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633962733?lang=en_us&edition=fundamental","pubTime":"2026-05-05 07:08","pubTimestamp":1777936080,"startTime":"0","endTime":"0","summary":"TORONTO, May 4, 2026 /CNW/ - To the Holders of Common Shares of Labrador Iron Ore Royalty Corporation. The Directors of Labrador Iron Ore Royalty Corporation  present the first quarter report for the period ended March 31, 2026.IOC sells CFS based on the Platts index for 65% Fe, CFR China . All references to tonnes and per-tonne prices in this report refer to wet metric tonnes, other than references to Platts quoted pricing, which refer to dry metric tonnes. Historically, IOC's wet ore contains approximately 3% less ore per equivalent volume than dry ore. In the first quarter of 2026, the 65% Fe index averaged US$121 per tonne, a 2% increase over the prior quarter and a 3% increase over the average of US$117 per tonne in the first quarter of 2025. IOC sells blast furnace  pellets and direct reduction  pellets based on a premium to the 65% Fe index. In 2026, Platts began publishing a new Atlantic Iron","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","FOR","BK4139","LU0053671581.USD","BK4024"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631852772","title":"Press Release: CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER PRODUCTION AND SALES","url":"https://stock-news.laohu8.com/highlight/detail?id=2631852772","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631852772?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:17","pubTimestamp":1777501020,"startTime":"0","endTime":"0","summary":"-- Quarterly production of 3.4M wmt, sales of 3.5M dmt and cash costs of. -- DRPF project commissioning advancing as planned, with initial production. tests successfully completed in March 2026 and production of commercially. sellable product expected by the end of calendar Q2 2026. -- The previously announced acquisition of Rana Gruber, a proven high-purity. Champion will host a conference call and webcast on May 28, 2026, at 9:00 AM  / 11:00 PM  to discuss the results of the fourth quarter and financial year ended March 31, 2026. The conference call details are set out at the end of this press release.concentrate for the three-month period ended March 31, 2026, an 8%. increase over the same prior-year period, and comparable to that of the. second quarter of the 2026 financial year, during which the Company also. until the rail operator's activities resumed to normal, as well as","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531193","title":"Disc Medicine announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531193","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631531193?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:22","pubTimestamp":1777411344,"startTime":"0","endTime":"0","summary":"Disc Medicine annual stockholder meeting set for June 18, 2026 in virtual format.Shareholders will vote on election of three Class III directors to serve until 2029.Ballot includes non-binding advisory vote on compensation for named executive officers.Meeting agenda also includes ratification of Ernst & Young as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL4WxPhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630458575","title":"Mabwell Q1 net loss narrows to RMB 241.94 million; revenue triples to RMB 127.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2630458575","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630458575?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:44","pubTimestamp":1777387472,"startTime":"0","endTime":"0","summary":"Mabwell posted a first-quarter net loss attributable to shareholders of RMB 241.94 million, narrowing from a year earlier, while basic earnings per share improved to RMB -0.61.Revenue more than tripled to RMB 127.6 million, driven by revenue recognized from a license agreement with DISC Medicine and higher pharmaceutical product sales.Operating loss narrowed to RMB 238.88 million as operating costs climbed to RMB 356.75 million.R&D investment fell 21.12% to RMB 164.5 million, while net cash used in operating activities widened to RMB 234.16 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabwell  Bioscience Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLgZDzQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688062","IRON","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842378","title":"Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842378","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842378?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:15","pubTimestamp":1777036517,"startTime":"0","endTime":"0","summary":"Disc Medicine recently reported that its Chief Medical Officer, William Jacob Savage, sold 5,731 shares under a pre-arranged 10b5-1 trading plan while its lead program, bitopertin, continues in the Phase 3 APOLLO study with topline data expected later this year.\nSeparately, the company said it will present new Phase 2 RALLY-MF trial data for DISC-0974 in anemia of myelofibrosis at the upcoming ASCO Annual Meeting, building on earlier results that showed unusually strong anemia response rates...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/will-insider-10b5-1-sales-and-new-asco-data-shift-disc-medic","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/will-insider-10b5-1-sales-and-new-asco-data-shift-disc-medic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629776859","title":"Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629776859","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629776859?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:31","pubTimestamp":1776961895,"startTime":"0","endTime":"0","summary":"Disc Medicine, Inc. ($IRON) announced an update on their ongoing clinical study. Disc Medicine, Inc. (IRON) has completed a Phase 1b trial titled “...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/disc-medicine-completes-key-phase-1b-study-of-disc-0974-in-ckd-anemia-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/disc-medicine-completes-key-phase-1b-study-of-disc-0974-in-ckd-anemia-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4211","ISBC","IRON","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629203743","title":"Disc Medicine to present Phase 2 RALLY-MF data for DISC-0974 at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629203743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629203743?lang=en_us&edition=fundamental","pubTime":"2026-04-21 22:01","pubTimestamp":1776780111,"startTime":"0","endTime":"0","summary":"Disc Medicine flagged additional Phase 2 RALLY-MF trial data for investigational anemia drug DISC-0974 in myelofibrosis for oral presentation at ASCO Annual Meeting on June 2, 2026.Earlier RALLY-MF results were already presented, with management characterizing initial anemia responses as unusually strong for this hard-to-treat patient group.Upcoming ASCO presentation is set to include a more complete dataset, including added results from patients receiving transfusions.Abstract is scheduled to post on ASCO website on May 21, 2026, with new analyses reserved for conference presentation.DISC-0974 remains investigational, with no approvals for use in any jurisdiction.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL65dH1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4588","LU2210150020.SGD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","BK4139","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","SG9999014013.SGD","SG9999014021.USD","IE00BKPKM429.USD","IRON","LU0053671581.USD","LU2095319765.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629174037","title":"Disc Medicine Announces Oral Presentation of Data From Rally-Mf Phase 2 Trial of Disc-0974 in Patients With Myelofibrosis and Anemia at the American Society of Clinical Oncology (Asco) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629174037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629174037?lang=en_us&edition=fundamental","pubTime":"2026-04-21 22:00","pubTimestamp":1776780000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUA4N918C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRON","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627258161","title":"Disc Medicine CMO William Jacob Savage disposes of $379,087 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627258161","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627258161?lang=en_us&edition=fundamental","pubTime":"2026-04-16 05:06","pubTimestamp":1776287163,"startTime":"0","endTime":"0","summary":"Disc Medicine Chief Medical Officer William Jacob Savage sold 5,731 shares on April 13, 2026.Sales priced at USD 66.12 per share for 3,531 shares.Additional 2,200 shares sold at USD 66.81 per share.Directly held stake fell to 79,480 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL8wXdHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627585482","title":"Disc Medicine CFO Jean M. Franchi disposes of USD 460,996 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627585482","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627585482?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:54","pubTimestamp":1776286467,"startTime":"0","endTime":"0","summary":"Disc Medicine CFO Jean M. Franchi sold 6,657 shares of common stock in transactions dated April 13-14.Sales prices were USD 69 per share on April 13 and about USD 69.24 per share on April 14.Franchi beneficially owned 64,333 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL4TZKgX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Disc Medicine CFO Jean M. Franchi disposes of USD 460,996 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601133","title":"Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601133","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625601133?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:18","pubTimestamp":1775506712,"startTime":"0","endTime":"0","summary":"Disc Medicine, Inc. recently reported that the last participant has been randomized and dosed in its expanded pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic and X-linked protoporphyria, while the program also faces an FDA Complete Response Letter citing insufficient efficacy in earlier trials.\nThis combination of advancing a potentially first disease-modifying therapy in a rare blood disorder and addressing regulatory efficacy concerns creates a complex risk-reward profile for...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/disc-medicine-iron-is-up-72-after-advancing-bitopertin-phase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/disc-medicine-iron-is-up-72-after-advancing-bitopertin-phase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","LABU","IRON","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624069038","title":"Assessing Disc Medicine (IRON) Valuation After FDA Complete Response Letter And Shareholder Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2624069038","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624069038?lang=en_us&edition=fundamental","pubTime":"2026-04-04 19:22","pubTimestamp":1775301764,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) is back in focus after the FDA issued a Complete Response Letter for its bitopertin program, triggering a 22% one day share price drop and a shareholder rights investigation.\nSee our latest analysis for Disc Medicine.\nBeyond the sharp reaction to the FDA Complete Response Letter and the shareholder rights investigation, Disc Medicine’s recent 7 day share price return of 8.47% and 30 day share price return of 8.02% sit alongside a 90 day share price return of 17.59% and a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/assessing-disc-medicine-iron-valuation-after-fda-complete-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iron/disc-medicine/news/assessing-disc-medicine-iron-valuation-after-fda-complete-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IRON","DCF","BK4585","BK4588","LU0053671581.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622686824","title":"Wedbush Keeps Their Buy Rating on Disc Medicine (IRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622686824","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622686824?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:55","pubTimestamp":1774616125,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten maintained a Buy rating on Disc Medicine today and set a price target of $88.00. According to TipRanks, Nierenga...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622997428","title":"BRIEF-Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic Protoporphyria","url":"https://stock-news.laohu8.com/highlight/detail?id=2622997428","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622997428?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:48","pubTimestamp":1774558110,"startTime":"0","endTime":"0","summary":"BRIEF-Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic ProtoporphyriaMarch 26 (Reuters) - Disc Medicine Inc IRON.O:DISC MEDICINE ANNOUNCES COMPL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nTUA9CHSSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRON","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622899243","title":"Disc Medicine completes Phase 3 APOLLO enrollment for bitopertin in EPP; trial size grows to 183 participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899243","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899243?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:44","pubTimestamp":1774557867,"startTime":"0","endTime":"0","summary":"Disc Medicine reported that the last participant has been randomized and dosed in the Phase 3 APOLLO trial evaluating bitopertin in erythropoietic protoporphyria.Enrollment was expanded to 183 participants from 150 participants.APOLLO is a double-blind, placebo-controlled study in patients ages 12 and above with erythropoietic protoporphyria and X-linked protoporphyria.Co-primary endpoints include average monthly total time in sunlight without pain between 10:00 and 18:00 and percent change from baseline in whole blood metal-free PPIX after 6 months.Study results have not been presented and are expected in Q4 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL8VpJQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622992878","title":"Disc Medicine completes enrollment in APOLLO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2622992878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622992878?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:36","pubTimestamp":1774557389,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) announced that the last participant has been randomized and dosed in the pivotal Phase 3 APOLLO trial of bitopertin in EPP. Or...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-completes-enrollment-in-apollo-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-completes-enrollment-in-apollo-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":105,"code":"91000000","status":"200"}]}}